Dr. Jonathan Emerson Buttram is a Bethesda, Maryland based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Jonathan Emerson Buttram is MD51393 for Ophthalmic Plastic and Reconstructive Surgery in South Carolina. Dr. Jonathan Emerson Buttram is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Jonathan Emerson Buttram speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1811356462
NPI Enumeration Date:
10 Feb, 2016
NPI Last Update On:
31 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jonathan Emerson Buttram are as mentioned below.
License Number
Specialization
State
Status
MD51393
Ophthalmic Plastic and Reconstructive Surgery
South Carolina
Primary
MD51393
Ophthalmology
South Carolina
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8901 Rockville Pike, Bethesda, Maryland
Zip:
20889-0001
Phone Number:
301-295-1339
Fax Number:
--
Patients can reach Dr. Jonathan Emerson Buttram at 8901 Rockville Pike, Bethesda, Maryland or can call to book an appointment on 301-295-1339. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.